Allothera

Allothera develops first-in-class non-opioid small molecule therapies to treat touch-to-pain conditions for neuropathic pain patients. We treat pain at its source through our novel mode-of-action targeting STOML3 inhibition, through its expression specifically in peripheral sensory neurons rather th... Read more